Abstract:Objective To investigate the genetic diagnosis and molecular pathogenesis of four patients with combined deficiency of coagulation factor Ⅴ and Ⅷ and their family members. Methods The APPT, FT, FⅤ: C, FⅧ: C were detected for phenotypic diagnosis. Thrombin generation assay was applied to determine the generation condition of thrombin in patients and healthy controls. Cenomic DNA was extracted from peripheral blood using the TianGen RelaxCene Blood DNA System;amniotic fluid DNA was extracted with phenol-ethyl ether method. The LMAN1 and MCFD2 genes were analyzed by PCR. Gene mutations were detected with nucleotid sequences by using end-labeling dideoxy method. Results The APTT of Proband 1 was significantly prolonged to 88. 2s and her PT was prolonged to 19. 6 s. The combined deficiency was identified with FⅧ (FⅧ: C 24. 2% ) and FV(FⅤ: C 9. 1% ). Proband 2 and 3 were sisters. The coagulation studies revealed that both of them had prolonged APTT (71.6 s and 74.6 s respectively) and PT (22. 1 s and 18. 3 s respectively). The combined deficiency of FⅤ (FⅤ: C 7. 6% and 14. 5% respectively) and FⅧ( FⅧ: C 25% and 19.6% respectively) were identified. Proband 4 was detected to have the prolonged APTT (70.3 s),PT (18.2 s) and the deficiency of FⅤ(FⅤ: C 9. 4% ) and FⅧ (15. 7% ). The remaining phenotype indicators test of the 4 probands were normal. The diagnosis for the 4 probands was combined deficiency of factor Ⅴ and Ⅷ. The proband 1 was detected to have compound heterozygous mutations in LMAN1 gene while having the LMAN1 and MCFD2 direct gene sequencing. One mutation was a small insertion located on exon 8 [ nt912insA (X71661. 1)] that resulted in p. 305frameshiftX20 and her mother was detected to have the same heterozygous mutation on the the locus. The other mutation was located on exon 11: nt1366C \u003e CT ( X71661. 1 ) , p. 456Arg \u003e Stop which was inherited from her father. Amniocyte DNA was detected to have only one heterozygous mutaion [nt1366C \u003e CT (X71661. 1) , 456Arg \u003e Stop] inherited from the father. No mutation in MCFD2 gene was found in proband 1 and her parents. The analysis of the MCFD2 gene in proband 2 and 3 revealed a novel homozygous single base substitution (nt411T\u003eC) in exon 4, which results in the exchange of the amino acid isoleucine by the amino acid threonine at amino acid position 136 (p. Ile136Thr). Sequencing of the whole LMAN1 gene showed that the proband 4 had one homozygous nonsence mutation in the exon 5 of the LMAN1 ( nt615C \u003eT,p. 202 Arg\u003e Stop). All of the 4 probands with combined deficiency of FⅤ and FⅧ showed declined endogenous thrombin potential in the thrombin generation tests. Conclusion The combined deficiency of FⅤ and FⅧ in the proband 1 results from the compound heterozygous mutations ( nt1366C \u003e CT and nt912insA) in LMAN1 gene, which are inherited from her parents respectively. The prenatal genetic investigation for the patient mother with preganency indicates that the fetus is a female carrier with one mutation (nt1366C \u003e CT) inherited from the father. The homozygous missence mutation ( nt411T \u003e C, p. Ile136Thr) in the MCFD2 gene accounts for the proband 2 and 3. The daughter of the proband 2 is a carrier with a heterozygous mutation inherited from her mother. The homozygous nonsence mutation in the LMAN1 gene of the proband 4 results in the deficency of F Ⅴ and FⅧ.\r\n\r\nKey words: \r\nFactor Ⅴ deficiency; Factor Ⅷ deficiency; Membroane proteins; Mannose-binding lectin; Vesicular transport proteins; Pedigree

Laboratory Diagnosis of a Pedigree with Inherited Coagulation Factor V Deficiency

[Analysis of Phenotype and Genotype in Four Chinese Pedigrees with Inherited Coagulation Factor V Deficiency.].

Genetic analysis of patients with hereditary coagulation factor Ⅺ deficiency and literatures review

Two Novel Factor V Gene Mutations Associated with Congenital Coagulation Factor V Deficiency, Study of One Pedigree

[Clinical and Genetic Analyses of Hereditary Factor Ⅴ Deficiency Cases].

Severe hereditary coagulation factor V deficiency caused by two novel heterozygous mutations]

Analysis of Clinical Phenotype and Genotype of Two Hereditary Coagulation Factor Ⅻ Deficiency

Investigation on Gene Defects in a Pedigree with Inherited Coagulation Factor Ⅺ Deficiency

Genetic Mutation Analysis of a Pedigree with Hereditary Coagulation Factor Ⅻ Deficiency Caused by Two Compound Heterozygous Mutations : Arg36Gln and Ala324Pro

Identification of Gene Mutations in Two Coagulation Factor V Deficiency Patients

Gene Analysis of Five Inherited Factor V Deficiency Cases

Type I Coagulation Factor V Deficiency Caused by Compound Heterozygous Mutation of F5 Gene

Ser234Leu Missense Mutation in the A1 Domain of Factor V Causing Moderate Factor V Deficiency in a Chinese Family

[Molecular Genetic Analysis for a Pedigree with Severe Hereditary Coagulation Factor VII Deficiency].

[Analysis of a Chinese pedigree affected with Hereditary FⅫ deficiency due to compound heterozygous variants of F12 gene]

[Studies on Inherited Coagulation Factor VII Deficiency and Tissue Factor Abnormality in a Pedigree].

[Analysis of A Pedigree with Hereditary Coagulation Factor Ⅻ Deficiency Caused by Compound Heterozygous Mutations].

Genetic diagnosis of four combined deficiency of factor V and VIII patients

Identification of a F11 Gene Missense Mutation Gly400Val in a Chinese Pedigree of Congenital Coagulation Factor Ⅺ Deficiency

Identification of a novel mutation of human blood coagulation FV gene associated with congenital FV deficiency]

[Genotype and Phenotype Analysis of Congenital Coagulator Factor VII Deficiency in Four Chinese Pedigrees].